Industry / innovation partners

Ovarian Cancer May Finally Have a Way to Drug p53

Myositis Finally Gets a Targeted Signal

Bayer’s ESC 2026 programme puts the heart-kidney axis centre stage. Disease silos are starting to look obsolete

Gut bacteria could help explain how vegetable-rich diets protect cardiometabolic health

Breast Cancer Immunotherapy Has a New Problem: Who Gets the Second Checkpoint?

Small-Cell Lung Cancer Gets an ADC Signal With Teeth

Myeloma Gets an Accelerated Approval. The Endpoint Is the Politics.

Parkinson’s Gets Fast Track, Not Fast Proof

345 Salmonella Cases Later, The Supply Chain Is Still Being Reconstructed.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
